Weekly Recap | Aktis Oncology -13.86%, sliding through key short-term averagesWeekly Review·Sep 12 at 05:56 AMAKTS+1.34%
Weekly Recap | Aktis Oncology +4.93%, most brokers rate it buyWeekly Review·Sep 5 at 06:07 AMAKTS+1.34%
